Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Promising signs in UC research into treating ovarian cancer

Promising signs in UC research into treating ovarian cancer

October 17, 2012

A University of Canterbury (UC) research project in collaboration with the Christchurch School of Medicine has shown some promising signs in the treatment of ovarian cancer.

UC student researcher Simon Hogg said ovarian cancer was a challenging disease to treat and was classed as the most lethal gynaecological cancer.

Without effective methods for screening and early detection, patients are typically not diagnosed until the disease has spread beyond the ovary and can become resistant to anti-cancer drugs. There is a desperate need for a new anti-cancer drug to improve the survival of women with advanced disease, Hogg said today.

He said his research found that naturally-occurring compounds could be employed to fight ovarian cancer.

``We are beginning to realise the clinical potential of these compounds. My study adds to a growing body of knowledge identifying naturally-occurring compounds in our diet which help fight against cancer. This is an exciting opportunity because compared to many synthetic drugs, naturally-occurring compounds are cheap, non-toxic, and easily accessible to the general public.

``Ongoing research at UC in collaboration with Dr Kenny Chitcholtan from the Department of Obstetrics and Gynaecology at the Christchurch School of Medicine aims to shed further light on compounds present in food and beverages that may be useful for entirely natural therapeutic interventions.

``Data I collected is consistent with the idea that lifestyle factors are associated with the rates of certain cancers, notably through dietary exposure. The identification of these compounds present in food and beverages that play anti-tumour roles against cancer is important for completing our understanding of the disease itself and guiding the design of new therapeutics.’’

Hogg’s research, supervised by UC’s Dr Ashley Garrill, studied the anti-tumour effects in advanced ovarian cancer cells. Results from his study suggested further investigation was warranted.

``The compounds used in my research were all naturally-occurring compounds produced by plants. The problem was that the compound (resveratrol) was quickly eliminated from the body before it could exert a beneficial effect.

``My results are significant as they suggest acetyl-resveratrol has similar anti-tumour activity to the parental compound, resveratrol. I believe that natural-occurring compounds are a feasible source of chemicals that can be employed to fight cancer,’’ Hogg said.

He will deliver his findings at the UC’s annual science biology conference on campus today.
ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Media: Julian Wilcox Leaves Māori TV

Māori Television has confirmed the resignation of Head of News and Production Julian Wilcox. Mr Maxwell acknowledged Mr Wilcox’s significant contribution to Māori Television since joining the organisation in 2004. More>>

ALSO:

Genetics: New Heat Tolerant Cow Developed

Hamilton, New Zealand-based Dairy Solutionz Ltd has led an expert genetics team to develop a new dairy cow breed conditioned to thrive in lower elevation tropical climates and achieve high milk production under heat stress. More>>

Fractals: Thousands More Business Cards Needed To Build Giant Sponge

New Zealand is taking part in a global event this weekend to build a Menger Sponge using 15 million business cards but local organisers say they are thousands of business cards short. More>>

Scoop Business: NZ Net Migration Rises To Annual Record In September

New Zealand’s annual net migration rose to a record in September, beating government forecasts, as the inflow was spurred by student arrivals from India and Kiwis returning home from Australia. More>>

ALSO:

Scoop Business: Fletcher To Close Its Christchurch Insulation Plant, Cut 29 Jobs

Fletcher Building, New Zealand’s largest listed company, will close its Christchurch insulation factory, as it consolidates its Tasman Insulations operations in a “highly competitive market”. More>>

ALSO:

Scoop Business: Novartis Adds Nine New Treatments Under Pharmac Deal

Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. More>>

ALSO:

Crown Accounts: English Wary On Tax Take, Could Threaten Surplus

Finance Minister Bill English is warning the tax take may come in below forecast in the current financial year, as figures released today confirm it was short by nearly $1 billion in the year to June 30 and English warned of the potential impact of slumping receipts from agricultural exports. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand

Mosh Social Media
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news